Biotech Brass Misled Investors About Cancer Drugs, Suit Says

By Sydney Price · November 13, 2024, 7:17 PM EST

Executives and directors of biotechnology company Agenus Inc. have been hit with a shareholder derivative suit in Massachusetts federal court alleging that the company misled investors about the effectiveness of its...

To view the full article, register now.